Product NDC: | 51292-111 |
Proprietary Name: | IPRIVASK |
Non Proprietary Name: | DESIRUDIN |
Active Ingredient(s): | & nbsp; DESIRUDIN |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51292-111 |
Labeler Name: | CANYON PHARMACEUTICALS, INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021271 |
Marketing Category: | NDA |
Start Marketing Date: | 20100830 |
Package NDC: | 51292-111-12 |
Package Description: | 10 KIT in 1 BOX (51292-111-12) > 1 KIT in 1 KIT * 15.75 mg in 1 VIAL, SINGLE-DOSE (51292-121-01) * .6 mL in 1 SYRINGE (51292-131-01) |
NDC Code | 51292-111-12 |
Proprietary Name | IPRIVASK |
Package Description | 10 KIT in 1 BOX (51292-111-12) > 1 KIT in 1 KIT * 15.75 mg in 1 VIAL, SINGLE-DOSE (51292-121-01) * .6 mL in 1 SYRINGE (51292-131-01) |
Product NDC | 51292-111 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DESIRUDIN |
Dosage Form Name | KIT |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20100830 |
Marketing Category Name | NDA |
Labeler Name | CANYON PHARMACEUTICALS, INC |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |